β-Catenin Inhibitor ICAT Modulates the Invasive Motility of Melanoma Cells

Inhibitor of β-catenin and TCF (ICAT) inhibits β-catenin transcriptional activity by competing with T-cell factor/lymphoid enhancer factor. We documented high ICAT levels in human melanoma cells, in which β-catenin signaling is frequently deregulated, finding a correlation with the capacity to form...

Full description

Saved in:
Bibliographic Details
Published in:Cancer research (Chicago, Ill.) Ill.), 2014-04, Vol.74 (7), p.1983-1995
Main Authors: DOMINGUES, Mélanie J, RAMBOW, Florian, JOB, Bastien, PAPON, Laura, WANGUO LIU, LARUE, Lionel, BONAVENTURE, Jacky
Format: Article
Language:English
Subjects:
Adaptor Proteins, Signal Transducing - physiology
Animals
Antineoplastic agents
beta Catenin - physiology
Biological and medical sciences
Cell Line, Tumor
Cell Movement
Dermatology
Humans
Intracellular Signaling Peptides and Proteins - physiology
Lung Neoplasms - pathology
Lung Neoplasms - secondary
Medical sciences
Melanoma - mortality
Melanoma - pathology
Melanoma - secondary
Mice
Mice, Nude
Multiple tumors. Solid tumors. Tumors in childhood (general aspects)
Neoplasm Invasiveness
Pharmacology. Drug treatments
Phosphoproteins - physiology
Tumors
Tumors of the skin and soft tissue. Premalignant lesions
Citations: Items that this one cites
Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:Inhibitor of β-catenin and TCF (ICAT) inhibits β-catenin transcriptional activity by competing with T-cell factor/lymphoid enhancer factor. We documented high ICAT levels in human melanoma cells, in which β-catenin signaling is frequently deregulated, finding a correlation with the capacity to form metastases in nude mice. Ectopic expression of ICAT in melanoma cells did not affect their proliferation but increased cell motility and Matrigel invasion of metastatic cells in a manner relying upon stable ICAT-β-catenin interaction. This effect was associated with conversion of an elongated/mesenchymal phenotype to a round/amoeboid phenotype in the absence of similar effects on elongated morphology of nonmetastatic melanoma cells. Transition from mesenchymal to amoeboid movement was associated with decreased levels of NEDD9 and activated Rac1, a positive regulator of mesenchymal movement. Ectopic ICAT promoted colonization of melanoma cells in the lungs of nude mice, suggesting an increase in metastatic potential. Together, our results showed that by downregulating Rac signaling in metastatic melanoma cells, ICAT increased their invasive motility by promoting a morphologic variation that facilitates a favorable adaptation to their microenvironment.
ISSN:0008-5472
1538-7445
DOI:10.1158/0008-5472.CAN-13-0920